Switch to:
More From Other Websites
TESARO Seeks FDA Approval for NK-1 Receptor Rolapitant Sep 09 2014
OPKO Licensee TESARO Submits New Drug Application for Rolapitant Sep 08 2014
TESARO Announces Submission of Rolapitant New Drug Application (NDA) to U.S. Food and Drug... Sep 08 2014
TESARO Announces Participation at Several Upcoming Investor Conferences Aug 21 2014
TESARO, INC. Financials Aug 01 2014
TESARO (TSRO) Slips on Wider-than-Expected Q2 Loss Jul 30 2014
TESARO, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 28 2014
TESARO, INC. Files SEC form 10-Q, Quarterly Report Jul 25 2014
TESARO, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 24 2014
TESARO Announces Second-Quarter 2014 Operating Results Jul 24 2014
TESARO Appoints Mary Lynne Hedley, Ph.D., as Chief Operating Officer Jul 24 2014
Q2 2014 TESARO Inc Earnings Release - After Market Close Jul 24 2014
Myriad Genetics Poised on Strong Fundamentals Jul 10 2014
TESARO to Announce Second-Quarter 2014 Financial Results on July 24, 2014 Jul 10 2014
[video] Biotech buys right now Jul 08 2014
Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher Jul 02 2014
TESARO Summarizes Rolapitant Data Presented at the 2014 MASCC/ISOO International Symposium on... Jun 27 2014
Cancer drug setback tarnishes AstraZeneca's R&D claims Jun 26 2014
TESARO, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... May 27 2014
TESARO appoints Tim Pearson as CFO May 27 2014


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK